Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 914162, 4 pages
http://dx.doi.org/10.1155/2012/914162
Review Article

Recent Advances in Dermatitis Herpetiformis

Department of Dermatology, Kochi Medical School, Kochi University, Kohasu, Okocho, Nankoku, Kochi 783-8505, Japan

Received 12 February 2012; Accepted 5 June 2012

Academic Editor: Marzia Caproni

Copyright © 2012 Kimiko Nakajima. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Bolotin and V. Petronic-Rosic, “Dermatitis herpetiformis: part I. Epidemiology, pathogenesis, and clinical presentation,” Journal of the American Academy of Dermatology, vol. 64, no. 6, pp. 1017–1024, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Bolotin and V. Petronic-Rosic, “Dermatitis herpetiformis: Part II. Diagnosis, management, and prognosis,” Journal of the American Academy of Dermatology, vol. 64, no. 6, pp. 1027–1033, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. R. G. Cardones and R. P. Hall, “Pathophysiology of dermatitis herpetiformis: A model for cutaneous manifestations of gastrointestinal inflammation,” Dermatologic Clinics, vol. 29, no. 3, pp. 469–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Alonso-llamazares, L. E. Gibson, and R. S. Rogers, “Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience,” International Journal of Dermatology, vol. 46, no. 9, pp. 910–919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. H. Cormane, “Immunoflurescent studies of the skin in lupus erythematosus and other diseases,” Pathologia Europ, vol. 2, pp. 170–180, 1967. View at Google Scholar
  6. H. Yaoita, “Identification of IgA binding structures in skin of patients with dermatitis herpetiformis,” Journal of Investigative Dermatology, vol. 71, no. 3, pp. 213–216, 1978. View at Google Scholar · View at Scopus
  7. V. A. Lightner, L. Y. Sakai, and R. P. Hall, “IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles,” Journal of Investigative Dermatology, vol. 96, no. 1, pp. 88–92, 1991. View at Google Scholar · View at Scopus
  8. J. D. Hendrix, K. L. Mangum, J. J. Zone, and W. R. Gammon, “Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils,” Journal of Investigative Dermatology, vol. 94, no. 5, pp. 667–672, 1990. View at Google Scholar · View at Scopus
  9. W. Dieterich, T. Ehnis, M. Bauer et al., “Identification of tissue transglutaminase as the autoantigen of celiac disease,” Nature Medicine, vol. 3, no. 7, pp. 797–801, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Sárdy, S. Kárpáti, B. Merkl, M. Paulsson, and N. Smyth, “Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis,” Journal of Experimental Medicine, vol. 195, no. 6, pp. 747–757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Preisz, M. Sárdy, A. Horváth, and S. Kárpáti, “Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis,” Journal of the European Academy of Dermatology and Venereology, vol. 19, no. 1, pp. 74–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Donaldson, J. J. Zone, L. A. Schmidt et al., “Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis,” Journal of Investigative Dermatology, vol. 127, no. 5, pp. 1268–1271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Zhang, B. Yang, Y. Lin et al., “Dermatitis herpetiformis in China: a report of 22 cases,” European Academy of Dermatology and Venereology, vol. 26, pp. 903–907, 2012. View at Publisher · View at Google Scholar
  14. C. J. Ko, O. R. Colegio, J. E. Moss, and J. M. McNiff, “Fibrillar IgA deposition in dermatitis herpetiformis—an underreported pattern with potential clinical significance,” Journal of Cutaneous Pathology, vol. 37, no. 4, pp. 475–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. P. Chorzelski, J. Sulej, and H. Tchorzewska, “IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease,” Annals of the New York Academy of Sciences, vol. 420, pp. 325–334, 1983. View at Google Scholar · View at Scopus
  16. T. D. Jaskowski, T. Hamblin, A. R. Wilson et al., “IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease,” Journal of Investigative Dermatology, vol. 129, no. 11, pp. 2728–2730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. N. J. Samolitis, C. M. Hull, K. M. Leiferman, and J. J. Zone, “Dermatitis herpetiformis and partial IgA deficiency,” Journal of the American Academy of Dermatology, vol. 54, no. 5, pp. S206–S209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. E. V. Marietta, M. J. Camilleri, L. A. Castro, P. K. Krause, M. R. Pittelkow, and J. A. Murray, “Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue,” Journal of Investigative Dermatology, vol. 128, no. 2, pp. 332–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Dahlbom, I. R. Korponay-Szabó, J. B. Kovács, Z. Szalai, M. Mäki, and T. Hansson, “Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, no. 2, pp. 140–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. P. Hall, K. M. Benbenisty, C. Mickle, F. Takeuchi, and R. D. Streilein, “Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten,” Journal of Investigative Dermatology, vol. 127, no. 9, pp. 2158–2165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Marietta, K. Black, M. Camilleri et al., “A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice,” Journal of Clinical Investigation, vol. 114, no. 8, pp. 1090–1097, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Zone, L. A. Schmidt, T. B. Taylor et al., “Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology,” Journal of Immunology, vol. 186, no. 7, pp. 4474–4480, 2011. View at Publisher · View at Google Scholar · View at Scopus